nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—adrenal gland cancer	0.608	0.767	CbGaD
Lapatinib—ABCB1—adrenal gland cancer	0.185	0.233	CbGaD
Lapatinib—TAP1—adrenal cortex—adrenal gland cancer	0.00425	0.0715	CbGeAlD
Lapatinib—PIK3C2B—adrenal cortex—adrenal gland cancer	0.00399	0.0671	CbGeAlD
Lapatinib—CYP2C19—urine—adrenal gland cancer	0.00365	0.0613	CbGeAlD
Lapatinib—TAP1—cardiac atrium—adrenal gland cancer	0.00351	0.0591	CbGeAlD
Lapatinib—TAP1—pituitary gland—adrenal gland cancer	0.00343	0.0578	CbGeAlD
Lapatinib—PIK3C2B—cardiac atrium—adrenal gland cancer	0.0033	0.0555	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—adrenal gland cancer	0.00322	0.0542	CbGeAlD
Lapatinib—TAP1—adrenal gland—adrenal gland cancer	0.00307	0.0516	CbGeAlD
Lapatinib—PI4KB—adrenal cortex—adrenal gland cancer	0.0029	0.0489	CbGeAlD
Lapatinib—PIK3C2B—adrenal gland—adrenal gland cancer	0.00288	0.0484	CbGeAlD
Lapatinib—Gefitinib—EGFR—adrenal gland cancer	0.00285	0.767	CrCbGaD
Lapatinib—ERBB2—gonad—adrenal gland cancer	0.00257	0.0432	CbGeAlD
Lapatinib—ERBB4—cardiac atrium—adrenal gland cancer	0.00257	0.0432	CbGeAlD
Lapatinib—ERBB4—pituitary gland—adrenal gland cancer	0.00251	0.0422	CbGeAlD
Lapatinib—PI4KB—gonad—adrenal gland cancer	0.00241	0.0405	CbGeAlD
Lapatinib—PI4KB—cardiac atrium—adrenal gland cancer	0.0024	0.0404	CbGeAlD
Lapatinib—PI4KB—pituitary gland—adrenal gland cancer	0.00235	0.0395	CbGeAlD
Lapatinib—ERBB2—adrenal gland—adrenal gland cancer	0.00224	0.0377	CbGeAlD
Lapatinib—CYP3A4—urine—adrenal gland cancer	0.00215	0.0363	CbGeAlD
Lapatinib—PI4KB—adrenal gland—adrenal gland cancer	0.0021	0.0353	CbGeAlD
Lapatinib—EGFR—adrenal gland—adrenal gland cancer	0.0019	0.0319	CbGeAlD
Lapatinib—Gefitinib—ABCB1—adrenal gland cancer	0.000865	0.233	CrCbGaD
Lapatinib—CYP2C8—pituitary gland—adrenal gland cancer	0.000681	0.0115	CbGeAlD
Lapatinib—ABCB1—adrenal cortex—adrenal gland cancer	0.000404	0.0068	CbGeAlD
Lapatinib—ABCB1—gonad—adrenal gland cancer	0.000335	0.00563	CbGeAlD
Lapatinib—ABCB1—pituitary gland—adrenal gland cancer	0.000327	0.0055	CbGeAlD
Lapatinib—ABCB1—adrenal gland—adrenal gland cancer	0.000292	0.00491	CbGeAlD
Lapatinib—ERBB4—DAP12 interactions—EGFR—adrenal gland cancer	0.000106	0.000739	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000106	0.000737	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—EGFR—adrenal gland cancer	0.000105	0.000734	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—EGFR—adrenal gland cancer	0.000105	0.000732	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	0.000105	0.000729	CbGpPWpGaD
Lapatinib—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000104	0.000727	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000104	0.000727	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SPRY2—adrenal gland cancer	0.000104	0.000726	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000104	0.000726	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—EGFR—adrenal gland cancer	0.000104	0.000723	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000103	0.000719	CbGpPWpGaD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000103	0.000716	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SPRY2—adrenal gland cancer	0.000103	0.000715	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MED12—adrenal gland cancer	0.000102	0.000709	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—EGFR—adrenal gland cancer	0.000102	0.000709	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000102	0.000708	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000101	0.000707	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000101	0.000706	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	9.99e-05	0.000696	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—BAD—adrenal gland cancer	9.99e-05	0.000696	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—BAD—adrenal gland cancer	9.99e-05	0.000696	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—EGFR—adrenal gland cancer	9.97e-05	0.000694	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—BAD—adrenal gland cancer	9.9e-05	0.00069	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—EGFR—adrenal gland cancer	9.82e-05	0.000684	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	9.81e-05	0.000683	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—BAD—adrenal gland cancer	9.77e-05	0.00068	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—BRAF—adrenal gland cancer	9.76e-05	0.00068	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	9.76e-05	0.00068	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MEN1—adrenal gland cancer	9.55e-05	0.000665	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	9.54e-05	0.000664	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	9.51e-05	0.000662	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—BRAF—adrenal gland cancer	9.48e-05	0.00066	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—BAD—adrenal gland cancer	9.44e-05	0.000657	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MEN1—adrenal gland cancer	9.41e-05	0.000656	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.4e-05	0.000655	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	9.4e-05	0.000654	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SH3KBP1—adrenal gland cancer	9.26e-05	0.000645	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—BAD—adrenal gland cancer	9.24e-05	0.000644	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.17e-05	0.000639	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	9.1e-05	0.000634	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—BRAF—adrenal gland cancer	9.09e-05	0.000633	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	8.85e-05	0.000616	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—CDC42—adrenal gland cancer	8.82e-05	0.000615	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—BRAF—adrenal gland cancer	8.59e-05	0.000598	CbGpPWpGaD
Lapatinib—EGFR—Disease—SH3KBP1—adrenal gland cancer	8.55e-05	0.000596	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	8.51e-05	0.000593	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CTNNB1—adrenal gland cancer	8.19e-05	0.00057	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—POMC—adrenal gland cancer	8.19e-05	0.00057	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	8.09e-05	0.000564	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	8.05e-05	0.000561	CbGpPWpGaD
Lapatinib—EGFR—Disease—ZNRF3—adrenal gland cancer	8.04e-05	0.00056	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—BAD—adrenal gland cancer	8.03e-05	0.000559	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNRH1—adrenal gland cancer	7.98e-05	0.000556	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—BAD—adrenal gland cancer	7.91e-05	0.000551	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—POMC—adrenal gland cancer	7.91e-05	0.000551	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PRKACA—adrenal gland cancer	7.9e-05	0.00055	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNRH1—adrenal gland cancer	7.86e-05	0.000548	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PRKACA—adrenal gland cancer	7.78e-05	0.000542	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—BAD—adrenal gland cancer	7.71e-05	0.000537	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—BAD—adrenal gland cancer	7.59e-05	0.000529	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	7.46e-05	0.00052	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—EGFR—adrenal gland cancer	7.34e-05	0.000511	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SPRY2—adrenal gland cancer	7.3e-05	0.000509	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PRKACA—adrenal gland cancer	7.29e-05	0.000508	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—EGFR—adrenal gland cancer	7.23e-05	0.000503	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SPRY2—adrenal gland cancer	7.19e-05	0.000501	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PRKACA—adrenal gland cancer	7.18e-05	0.0005	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSHR—adrenal gland cancer	7.12e-05	0.000496	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSHR—adrenal gland cancer	7.01e-05	0.000488	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.91e-05	0.000481	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—BAD—adrenal gland cancer	6.8e-05	0.000474	CbGpPWpGaD
Lapatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.8e-05	0.000474	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDC42—adrenal gland cancer	6.7e-05	0.000467	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MEN1—adrenal gland cancer	6.69e-05	0.000466	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—EGFR—adrenal gland cancer	6.64e-05	0.000462	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDC42—adrenal gland cancer	6.6e-05	0.00046	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MEN1—adrenal gland cancer	6.59e-05	0.000459	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PRKACA—adrenal gland cancer	6.56e-05	0.000457	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNRH1—adrenal gland cancer	6.53e-05	0.000455	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTGS2—adrenal gland cancer	6.53e-05	0.000455	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EGFR—adrenal gland cancer	6.49e-05	0.000452	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNRHR—adrenal gland cancer	6.44e-05	0.000449	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGS2—adrenal gland cancer	6.31e-05	0.000439	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	6.3e-05	0.000439	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CDC42—adrenal gland cancer	6.3e-05	0.000439	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PRKACA—adrenal gland cancer	6.3e-05	0.000439	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—CTNNB1—adrenal gland cancer	6.21e-05	0.000433	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—BRAF—adrenal gland cancer	6.19e-05	0.000431	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDC42—adrenal gland cancer	6.19e-05	0.000431	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.18e-05	0.000431	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDC42—adrenal gland cancer	6.09e-05	0.000424	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—adrenal gland cancer	6.05e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.99e-05	0.000417	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—CTNNB1—adrenal gland cancer	5.98e-05	0.000417	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TSHR—adrenal gland cancer	5.82e-05	0.000406	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SDHB—adrenal gland cancer	5.63e-05	0.000392	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ZNRF3—adrenal gland cancer	5.63e-05	0.000392	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDC42—adrenal gland cancer	5.56e-05	0.000387	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.52e-05	0.000384	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	5.46e-05	0.00038	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDC42—adrenal gland cancer	5.34e-05	0.000372	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CTNNB1—adrenal gland cancer	5.28e-05	0.000368	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—adrenal gland cancer	5.27e-05	0.000367	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.27e-05	0.000367	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CTNNB1—adrenal gland cancer	5.2e-05	0.000362	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PRKACA—adrenal gland cancer	5.11e-05	0.000356	CbGpPWpGaD
Lapatinib—EGFR—Disease—SPRY2—adrenal gland cancer	5.04e-05	0.000351	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PRKACA—adrenal gland cancer	5.03e-05	0.00035	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	4.96e-05	0.000346	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TERT—adrenal gland cancer	4.96e-05	0.000346	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TERT—adrenal gland cancer	4.89e-05	0.00034	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SDHB—adrenal gland cancer	4.88e-05	0.00034	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	4.87e-05	0.000339	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.74e-05	0.00033	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—adrenal gland cancer	4.74e-05	0.00033	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.7e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—BAD—adrenal gland cancer	4.68e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Disease—MEN1—adrenal gland cancer	4.62e-05	0.000322	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—BAD—adrenal gland cancer	4.61e-05	0.000321	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—adrenal gland cancer	4.56e-05	0.000317	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SDHB—adrenal gland cancer	4.36e-05	0.000303	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDC42—adrenal gland cancer	4.33e-05	0.000302	CbGpPWpGaD
Lapatinib—ERBB2—Disease—BAD—adrenal gland cancer	4.32e-05	0.000301	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDC42—adrenal gland cancer	4.27e-05	0.000297	CbGpPWpGaD
Lapatinib—ERBB4—Disease—BAD—adrenal gland cancer	4.25e-05	0.000296	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.25e-05	0.000296	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—adrenal gland cancer	4.18e-05	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PRKACA—adrenal gland cancer	4.18e-05	0.000291	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF2—adrenal gland cancer	4.18e-05	0.000291	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNAS—adrenal gland cancer	4.14e-05	0.000288	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—adrenal gland cancer	4.12e-05	0.000287	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.11e-05	0.000287	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF2—adrenal gland cancer	4.11e-05	0.000286	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNAS—adrenal gland cancer	4.08e-05	0.000284	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1R—adrenal gland cancer	4.04e-05	0.000281	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—adrenal gland cancer	4.02e-05	0.00028	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1R—adrenal gland cancer	3.98e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—adrenal gland cancer	3.96e-05	0.000276	CbGpPWpGaD
Lapatinib—ERBB2—Disease—BRAF—adrenal gland cancer	3.93e-05	0.000274	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—BAD—adrenal gland cancer	3.88e-05	0.00027	CbGpPWpGaD
Lapatinib—ERBB4—Disease—BRAF—adrenal gland cancer	3.87e-05	0.00027	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNRH1—adrenal gland cancer	3.86e-05	0.000269	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.84e-05	0.000268	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PRKACA—adrenal gland cancer	3.82e-05	0.000266	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—BAD—adrenal gland cancer	3.73e-05	0.00026	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—RRM1—adrenal gland cancer	3.63e-05	0.000253	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SDHD—adrenal gland cancer	3.63e-05	0.000253	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CDC42—adrenal gland cancer	3.54e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SPRY2—adrenal gland cancer	3.53e-05	0.000246	CbGpPWpGaD
Lapatinib—EGFR—Disease—PRKACA—adrenal gland cancer	3.53e-05	0.000246	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.49e-05	0.000243	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TERT—adrenal gland cancer	3.47e-05	0.000242	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSHR—adrenal gland cancer	3.44e-05	0.00024	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.43e-05	0.000239	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TERT—adrenal gland cancer	3.42e-05	0.000238	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNAS—adrenal gland cancer	3.39e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDC42—adrenal gland cancer	3.24e-05	0.000226	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MEN1—adrenal gland cancer	3.23e-05	0.000225	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.18e-05	0.000222	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—adrenal gland cancer	3.17e-05	0.000221	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—RRM1—adrenal gland cancer	3.14e-05	0.000219	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SDHD—adrenal gland cancer	3.14e-05	0.000219	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—adrenal gland cancer	3.13e-05	0.000218	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.12e-05	0.000217	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTNNB1—adrenal gland cancer	3.08e-05	0.000214	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTNNB1—adrenal gland cancer	3.03e-05	0.000211	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—BAD—adrenal gland cancer	3.02e-05	0.000211	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDC42—adrenal gland cancer	2.99e-05	0.000208	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—BAD—adrenal gland cancer	2.98e-05	0.000207	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.93e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CTNNB1—adrenal gland cancer	2.89e-05	0.000201	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CTNNB1—adrenal gland cancer	2.84e-05	0.000198	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—RRM1—adrenal gland cancer	2.81e-05	0.000196	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SDHD—adrenal gland cancer	2.81e-05	0.000196	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CTNNB1—adrenal gland cancer	2.8e-05	0.000195	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—POMC—adrenal gland cancer	2.79e-05	0.000194	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—BRAF—adrenal gland cancer	2.75e-05	0.000192	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—POMC—adrenal gland cancer	2.75e-05	0.000191	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.74e-05	0.000191	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.74e-05	0.000191	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—BRAF—adrenal gland cancer	2.71e-05	0.000189	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.71e-05	0.000189	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.62e-05	0.000182	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.58e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTNNB1—adrenal gland cancer	2.55e-05	0.000178	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.47e-05	0.000172	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKACA—adrenal gland cancer	2.47e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—adrenal gland cancer	2.44e-05	0.00017	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—adrenal gland cancer	2.4e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Disease—TERT—adrenal gland cancer	2.4e-05	0.000167	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.34e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—POMC—adrenal gland cancer	2.28e-05	0.000159	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BAD—adrenal gland cancer	2.26e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—adrenal gland cancer	2.25e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—adrenal gland cancer	2.22e-05	0.000154	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.1e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDC42—adrenal gland cancer	2.09e-05	0.000146	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MED12—adrenal gland cancer	2.09e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Disease—BAD—adrenal gland cancer	2.09e-05	0.000145	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.08e-05	0.000145	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MED12—adrenal gland cancer	2.04e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF2—adrenal gland cancer	2.02e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNAS—adrenal gland cancer	2e-05	0.000139	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.99e-05	0.000139	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.97e-05	0.000138	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CTNNB1—adrenal gland cancer	1.96e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1R—adrenal gland cancer	1.95e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Disease—BRAF—adrenal gland cancer	1.9e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.87e-05	0.00013	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.71e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.69e-05	0.000118	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.69e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TERT—adrenal gland cancer	1.68e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.67e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.6e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—adrenal gland cancer	1.58e-05	0.00011	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.57e-05	0.000109	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—adrenal gland cancer	1.55e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—adrenal gland cancer	1.53e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.53e-05	0.000106	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.49e-05	0.000104	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.49e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTNNB1—adrenal gland cancer	1.49e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BAD—adrenal gland cancer	1.46e-05	0.000102	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.39e-05	9.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CTNNB1—adrenal gland cancer	1.37e-05	9.56e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.36e-05	9.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—adrenal gland cancer	1.35e-05	9.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BRAF—adrenal gland cancer	1.33e-05	9.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—adrenal gland cancer	1.32e-05	9.22e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—adrenal gland cancer	1.3e-05	9.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.26e-05	8.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.24e-05	8.62e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.21e-05	8.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.21e-05	8.41e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.08e-05	7.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CTNNB1—adrenal gland cancer	9.62e-06	6.7e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—adrenal gland cancer	9.33e-06	6.5e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	9.18e-06	6.4e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.6e-06	5.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—adrenal gland cancer	8.33e-06	5.8e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—adrenal gland cancer	8.13e-06	5.66e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	7.45e-06	5.19e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.44e-06	5.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.3e-06	5.09e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	6.65e-06	4.63e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	6.49e-06	4.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—adrenal gland cancer	6.4e-06	4.46e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.01e-06	3.49e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4e-06	2.78e-05	CbGpPWpGaD
